Literature DB >> 23958462

Sinonasal squamous cell carcinomas: clinical outcomes and predictive factors.

J Michel1, N Fakhry2, J Mancini3, D Braustein3, E Moreddu2, A Giovanni2, P Dessi2.   

Abstract

This was a retrospective study of 33 patients treated for sinonasal squamous cell carcinoma between 1995 and 2008. Epidemiological, clinical, histological, and therapeutic aspects of this series of patients were analysed, and their impacts on overall survival and disease-free survival established using the Kaplan-Meier method. A search for prognostic factors was made using a log-rank test. There were 27 men. The average age at diagnosis was 64.7 years. Tobacco-smoking was found to be a risk factor in 24 patients (72.7%). The median follow-up was 66 months (range 0-99 months). Tumours were classified as T1 in 18.3%, T2 in 27.3%, T3 in 6%, and T4 in 48.5% of cases. Disease-free survival rates at 1 and 5 years were 58.5% and 46.1%, respectively, and overall survival rates were 70.3% and 40%, respectively. Overall survival was correlated to tumour status (TNM, American Joint Committee on Cancer) (P = 0.010) and involvement of key structures (skull base, dura mater, brain, orbit, cavernous sinus, infratemporal fossa, skin) (P = 0.049). Surgery followed by radiotherapy improved overall survival (P = 0.005) and disease-free survival (P = 0.028) when compared to other treatment modalities. When compared to surgery alone, it improved disease-free survival (P = 0.049) regardless of tumour stage.
Copyright © 2013 International Association of Oral and Maxillofacial Surgeons. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  radiotherapy; sinus carcinoma; surgery

Mesh:

Year:  2013        PMID: 23958462     DOI: 10.1016/j.ijom.2013.07.741

Source DB:  PubMed          Journal:  Int J Oral Maxillofac Surg        ISSN: 0901-5027            Impact factor:   2.789


  7 in total

Review 1.  Management of squamous cell carcinomas of the skull-base.

Authors:  Colin G Leonard; Vikram Padhye; Ian J Witterick
Journal:  J Neurooncol       Date:  2020-06-05       Impact factor: 4.130

2.  Prognostic Factors in Paranasal Sinus Squamous Cell Carcinoma and Adenocarcinoma: A SEER Database Analysis.

Authors:  Sumit Jain; Yan Li; Edward C Kuan; Bobby A Tajudeen; Pete S Batra
Journal:  J Neurol Surg B Skull Base       Date:  2018-08-24

3.  Comparative outcome of surgical and nonsurgical therapy for T4bN0M0 sinonasal squamous cell carcinomas.

Authors:  Ruichen Li; Shu Tian; Lan Lin; Quan Liu; Shengzi Wang
Journal:  Eur Arch Otorhinolaryngol       Date:  2019-08-26       Impact factor: 2.503

4.  Locally advanced paranasal sinus carcinoma: A study of 30 patients.

Authors:  Francesco Perri; Raffaele Addeo; Manuel Conson; Adriana Faiella; Giuseppina Della Vittoria Scarpati; Gabriella Torre; Angela Di Biase; Paola Romanelli; Carlo Buonerba; Giuseppe Di Lorenzo; Antonio Daponte; Francesco Caponigro; Salvatore Pisconti; Roberto Pacelli; Vincenzo Ravo; Paolo Muto; Raffaele Solla
Journal:  Oncol Lett       Date:  2017-01-11       Impact factor: 2.967

5.  Factors associated with a primary surgical approach for sinonasal squamous cell carcinoma.

Authors:  Jennifer R Cracchiolo; Krupa Patel; Jocelyn C Migliacci; Luc T Morris; Ian Ganly; Benjamin R Roman; Sean M McBride; Viviane S Tabar; Marc A Cohen
Journal:  J Surg Oncol       Date:  2017-11-28       Impact factor: 3.454

6.  The Role of Salvage in the Management of Patients with Sinonasal Squamous Cell Carcinoma.

Authors:  Urszula Kacorzyk; Tomasz Wojciech Rutkowski
Journal:  Biomedicines       Date:  2022-05-28

7.  Factors Contributing to Diagnosis and Prognosis in Sinonasal Malignancies.

Authors:  Wenjing Li; Jianqiang You; Haixiang Xue; Changjiang Chao
Journal:  J Immunol Res       Date:  2022-09-29       Impact factor: 4.493

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.